Patents by Inventor Stefan Weinert

Stefan Weinert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240185992
    Abstract: A device and method are disclosed for supporting a patient with a disease, comprising a display facility, a user interface, a processor, and a user interface, and with an application module comprising program instructions, which are configured, on executing by the processor to bring about the following: providing medical protocols for diagnostic and/or therapeutic purposes, collecting time information concerning a future event which is a trigger for at least one medical protocol, selecting one of the medical protocols which indicates a group of cohesive protocol events which are spaced apart chronologically over a protocol period in accordance with a protocol regime, monitoring a chronological interval between a current date and the future even, and issuing a user start notice concerning the beginning of the medical protocol at a time which from a chronological point of view lies at least by the protocol period before the future event.
    Type: Application
    Filed: January 17, 2024
    Publication date: June 6, 2024
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Matthias Essenpreis, Dirk Voelkel, Stefan Weinert
  • Patent number: 11907180
    Abstract: A structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof are disclosed which implement a structured collection procedure based on a medical use case and/or question which provides at least one or more parameters defining entry criterion, a schedule of events, adherence criterion, and exit criterion. The entry criterion establish conditions needed to be met prior to obtaining biomarker data from the patient. Each event can include one or more of a performance time, patient guidance to perform the event, a request for information from the patient a request for patient action, and a request for collection of biomarker data from the patient. The adherence criterion can be used to assess whether an event performed is acceptable to addressing the medical use case and/or question, and the exit criterion establishes conditions needed to be met prior to exiting the collection procedure.
    Type: Grant
    Filed: April 8, 2022
    Date of Patent: February 20, 2024
    Assignee: Roche Diabetes Care, Inc.
    Inventors: P. Douglas Walling, Juergen Rasch-Menges, Stefan Weinert, Steven Bousamra, Abhishek S. Soni, Christoph Eisenhardt
  • Publication number: 20220287563
    Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.
    Type: Application
    Filed: June 2, 2022
    Publication date: September 15, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
  • Publication number: 20220257118
    Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.
    Type: Application
    Filed: May 6, 2022
    Publication date: August 18, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Abhishek S. Soni, Paul J. Galley, Alan Greenburg, Steven Bousamra, Stefan Weinert, Erica Diebold
  • Publication number: 20220229818
    Abstract: A structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof are disclosed which implement a structured collection procedure based on a medical use case and/or question which provides at least one or more parameters defining entry criterion, a schedule of events, adherence criterion, and exit criterion. The entry criterion establish conditions needed to be met prior to obtaining biomarker data from the patient. Each event can include one or more of a performance time, patient guidance to perform the event, a request for information from the patient a request for patient action, and a request for collection of biomarker data from the patient. The adherence criterion can be used to assess whether an event performed is acceptable to addressing the medical use case and/or question, and the exit criterion establishes conditions needed to be met prior to exiting the collection procedure.
    Type: Application
    Filed: April 8, 2022
    Publication date: July 21, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: P. Douglas Walling, Juergen Rasch-Menges, Stefan Weinert, Steven Bousamra, Abhishek S. Soni, Christoph Eisenhardt
  • Patent number: 11382507
    Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: July 12, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
  • Patent number: 11350822
    Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: June 7, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Abhishek S. Soni, Paul J. Galley, Alan Greenburg, Steven Bousamra, Stefan Weinert, Erica Diebold
  • Patent number: 11327931
    Abstract: A structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof are disclosed which implement a structured collection procedure based on a medical use case and/or question which provides at least one or more parameters defining entry criterion, a schedule of events, adherence criterion, and exit criterion. The entry criterion establish conditions needed to be met prior to obtaining biomarker data from the patient. Each event can include one or more of a performance time, patient guidance to perform the event, a request for information from the patient a request for patient action, and a request for collection of biomarker data from the patient. The adherence criterion can be used to assess whether an event performed is acceptable to addressing the medical use case and/or question, and the exit criterion establishes conditions needed to be met prior to exiting the collection procedure.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: May 10, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: P. Douglas Walling, Juergen Rasch-Menges, Stefan Weinert, Steven Bousamra, Abhishek S. Soni, Christoph Eisenhardt
  • Patent number: 10915505
    Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, and data analysis of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor causes the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criterions being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criterions being met at some unknown time, and mark/indicate the structured collection procedure as completed if no exception occurred during performance of an event in the schedule of events.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: February 9, 2021
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Abhishek S. Soni, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, Steven Bousamra, Alan M. Greenburg
  • Publication number: 20200168328
    Abstract: A patient information collecting system may include a patient interface device, a patient notification device, an input device for entering patient information, and an information collecting unit having a processor programmed to activate the patient notification device at a specified time prior to occurrence of each of a plurality of scheduled events followed, for each such activation, by presenting instructions via the patient interface device to input to the information collecting unit, via the input device, information specified by the presented instructions and resulting from execution of a corresponding one of the plurality of scheduled events, the plurality of scheduled events including at least two of a scheduled patient glucose measuring event, a scheduled delivery of a diabetes therapy related drug to the patient, a scheduled meal or snack to be consumed by the patient and a scheduled physical activity to be undertaken by the patient.
    Type: Application
    Filed: January 30, 2020
    Publication date: May 28, 2020
    Inventors: Stefan Weinert, Nicole Bernini, Derek Brandt, Matthias Essenpreis, Kelly Heaton, Joel Jeckelmann, Sebastiaan LaBastide, Gunnar Meyer-Olden, Michael Schoemaker, Robin Wagner
  • Publication number: 20200151152
    Abstract: A structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof are disclosed which implement a structured collection procedure based on a medical use case and/or question which provides at least one or more parameters defining entry criterion, a schedule of events, adherence criterion, and exit criterion. The entry criterion establish conditions needed to be met prior to obtaining biomarker data from the patient. Each event can include one or more of a performance time, patient guidance to perform the event, a request for information from the patient a request for patient action, and a request for collection of biomarker data from the patient. The adherence criterion can be used to assess whether an event performed is acceptable to addressing the medical use case and/or question, and the exit criterion establishes conditions needed to be met prior to exiting the collection procedure.
    Type: Application
    Filed: January 7, 2020
    Publication date: May 14, 2020
    Applicant: Roche Diabetes Care, Inc.
    Inventors: P. Douglas Walling, Juergen Rasch-Menges, Stefan Weinert, Steven Bousamra, Abhishek S. Soni, Christoph Eisenhardt
  • Patent number: 10565170
    Abstract: A structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof are disclosed which implement a structured collection procedure based on a medical use case and/or question which provides at least one or more parameters defining entry criterion, a schedule of events, adherence criterion, and exit criterion. The entry criterion establish conditions needed to be met prior to obtaining biomarker data from the patient. Each event can include one or more of a performance time, patient guidance to perform the event, a request for information from the patient a request for patient action, and a request for collection of biomarker data from the patient. The adherence criterion can be used to assess whether an event performed is acceptable to addressing the medical use case and/or question, and the exit criterion establishes conditions needed to be met prior to exiting the collection procedure.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: February 18, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: P. Douglas Walling, Juergen Rasch-Menges, Stefan Weinert, Steven Bousamra, Abhishek S. Soni, Christoph Eisenhardt
  • Publication number: 20200015680
    Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.
    Type: Application
    Filed: September 23, 2019
    Publication date: January 16, 2020
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
  • Patent number: 10522247
    Abstract: Embodiments of methods of assessing a diabetes treatment protocol comprise determining a protocol complexity level corresponding to a degree of difficulty of completing the diabetes treatment protocol by utilizing the processor, determining a patient proficiency level corresponding to a skill set of the patient in conducting the diabetes treatment protocol by utilizing the processor, comparing the protocol complexity level to the patient proficiency level via the processor, and providing an output based on the comparison.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: December 31, 2019
    Inventors: Paul J. Galley, Stefan Weinert, David Hasker, Ulrich Porsch
  • Publication number: 20190385729
    Abstract: A method is disclosed for providing therapeutic guidelines to a person having diabetes. The method comprises measuring a blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person; recording the measured bG levels in a computing device; determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; an automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.
    Type: Application
    Filed: September 3, 2019
    Publication date: December 19, 2019
    Applicant: Roche Diagnostics Care, Inc.
    Inventors: Robin Wagner, Stefan Weinert, Remmert Laan, Kurt Waechter, Christen Rees
  • Publication number: 20190371467
    Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.
    Type: Application
    Filed: August 13, 2019
    Publication date: December 5, 2019
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Abhishek S. Soni, Paul J. Galley, Alan Greenburg, Steven Bousamra, Stefan Weinert, Eric Diebold
  • Patent number: 10456036
    Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: October 29, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
  • Patent number: 10437962
    Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: October 8, 2019
    Assignee: ROCHE DIABETES CARE INC
    Inventors: Abhishek S. Soni, Paul J. Galley, Alan Greenburg, Steven Bousamra, Stefan Weinert, Eric Diebold
  • Patent number: 10368745
    Abstract: Embodiments of a testing method for diabetics to optimize their administered insulin dosage comprise collecting sampling sets of biomarker data, each sampling set comprising a sufficient plurality of non-adverse sampling instances and each sampling instance comprising an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: August 6, 2019
    Assignee: ROCHE DIABETES CARE INC
    Inventors: Steven Bousamra, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, John F. Price, Heino Eikmeier, Birgit Kraeling, Karl Werner, Ulrich Porsch
  • Publication number: 20180168448
    Abstract: Embodiments of a testing method for diabetics to optimize their administered insulin dosage comprise collecting sampling sets of biomarker data, each sampling set comprising a sufficient plurality of non-adverse sampling instances and each sampling instance comprising an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.
    Type: Application
    Filed: February 2, 2018
    Publication date: June 21, 2018
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Steven Bousamra, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, Ajay Thukral, Heino Eikmeier, Birgit Kraeling, Karl Warner, Ulrich Porsch